Key developments: mRNA vaccines and therapeutics
European Pharmaceutical Review
FEBRUARY 14, 2023
Robust analytical methods are needed to establish safety, potency, and purity of mRNA therapeutics in large-scale manufacturing. Sarah Bundra, Pharmaceutical Analyst at GlobalData also warned about patient safety: “introducing mRNA carries the risk of activating the immune system.”
Let's personalize your content